Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match Biodexa Pharmaceuticals PLC (“Biodexa” ...
LONDON, ONTARIO -- (Marketwire) -- 05/18/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has initiated a project to develop an optimal oral formulation of ...
Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI ...
All academic programs at RIT are required to have a Program Level Outcomes Assessment Plan (PLOAP). The goal of an academic program assessment plan is to facilitate continuous program improvement. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results